CALVENZA®-03 EIV/EHV
Equine Rhinopneumonitis - Influenza Vaccine
- CALVENZA®-03 EIV/EHV is an equine rhinopneumonitis and influenza, killed virus vaccine for healthy horses 6 months of age or older, including pregnant mares, against:
- respiratory diseases due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4)
- equine influenza virus (EIV) types A2 North American and A2 Eurasian
- The first equine influenza vaccine updated to follow World Organisation for Animal Health (WOAH) guidelines to contain Florida sublineage clade 1
- Flexible administration - Give first and second doses IM at different injection sites; third dose may be given IM or IN. Allow 3–4 weeks between doses.
Features
- Incorporates Florida sublineage clade 1 (OH/03), Kentucky (KY/2/95), and Eurasian Newmarket/2/93 (NM/2/93) equine influenza strains
- Unique EHV-1 equine respiratory origin isolate
- CARBIMMUNE® adjuvant formulation
- ULTRAFIL™️ purification technology
- Includes innovative pliable nasal applicator
- Safe for use in foals as young as 6 months of age
- Proven safe in pregnant mares
Benefits
- Stimulates antibody production against EHV-1 & EHV-4
- CARBIMMUNE® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
- ULTRAFIL™️ purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
- Flexible dose administration using intramuscular or intranasal techniques
- Pregnant mare may be safely vaccinated in any stage of gestation
- Can initiate vaccination in foals as early as 6 months of age
Shake the bottle well before using. Using aseptic technique, inoculate horses intramuscularly (IM) with a 2mL dose.
Administer second 2mL dose IM in 3-4 weeks using a different injection site.
Administer a third 2mL dose in 3-4 weeks either by intramuscular or intranasal (IN) route.
The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
Precautions
- Store at a temperature between 35° - 46°F (2° - 8°C)
- Do not freeze
- Do not vaccinate within 21 days of slaughter
- Do not mix with other products
- Use entire contents after opening
In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.
CALVENZA® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. CARBIMMUNE® is a registered trademark and ULTRAFIL™️ is a trademark of Boehringer Ingelheim Animal Health USA Inc. ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0105-2021-V2